Form D · Biotechnology
Perimetrics, Inc.
Redmond, WA · CIK 0001924441
Offering snapshot reported Nov 7, 2025 · SEC filing
- Reported sold
- $9.43M Offering amount: $17.5M
- Investors reported
- 118 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 1, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2025 | Initial | $9,427,041 | No comparison | 118 | SEC filing |
| Sep 11, 2023 | Amendment | $7,789,121 | $5,669,026vs Apr 29, 2022 | 135 | SEC filing |
| Apr 29, 2022 | Initial | $2,120,095 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-563465
Source: Form D, filed Nov 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Earthman | Director |
| Sherry Fischer | Executive |
| David Gill | Director |
| Robert Hayman | Director, Executive |
| Bruce Kanter | Director |
| Clarence Puryear | Director |
| Rudy Puryear | Director |
| Kristine Romine | Director |
| Cherilyn Sheets | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8441 154 Th Avenue Ne, Bldg H 210
Redmond, WA, 98052
Redmond, WA, 98052